SERPINE1 and COVID-19: Our data on the Japanese COVID-19 patients demonstrated – in contrast to the study with Mexican COVID-19 patients (37) – that total PAI-1 and plasmin levels differed between genotypes of the 4G/5G, but not the +43 G>A PAI-1 polymorphism in COVID-19 patients.